RIBT--Bill Gates Gives Colorado State $1,000,000 to

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28

RIBT--Bill Gates Gives Colorado State $1,000,000 to "Unlocking the Global Health Potential of Rice Bran"

The article>>>

Unlocking the Global Health Potential of Rice Bran

Researchers at Colorado State University are in the early stages of understanding the beneficial mechanisms of rice bran in an innovative food-as-medicine endeavor that’s earned grant funding from the Gates Foundation.
By Joanna Cosgrove, Online Editor
Published January 10, 2013

Rice—white rice, in particular—is a food staple consumed by more than half of the world’s population. But it’s the bran of the rice, the outer hull that’s usually discarded, that’s drawn the intrigue of researchers at Colorado State University, who are studying it as a potential solution to gut immunity and long-term health, especially for children in developing and impoverished nations.

“Rice bran is rich in lipids and fatty acids that are beneficial to health but it’s typically polished off and discarded because it goes rancid,” explained Elizabeth Ryan, PhD, lead researcher and assistant professor in the College of Veterinary Medicine and Biomedical Sciences. “I wondered why we couldn’t overcome this. There’s plenty available; technologically we just need to figure out what to do with it.”

To that end, Dr. Ryan is currently pursuing a global health research project, titled “Studying How Rice Bran Augments Mucosal Immunity,” that will explore rice bran’s ability to fight off multiple gut pathogens (e.g., Salmonella and Rotovirus) that contribute to the morbidity and mortality of children around the world.

“The number of kids who are dying of diarrhea around the world every day deserves rigorous research attention with practical, wide-reaching solutions—there are so many pathogens, and over time it wears on your gut, immunity and ability to grow,” Dr. Ryan said. “It’s very hard to vaccinate against all these bugs at the exposure levels that exist.”

Despite its discarded byproduct status, Dr. Ryan said rice bran has been associated with a variety of health benefits, including cardiovascular benefits, and published animal studies detailing its colon and intestinal cancer fighting properties. The lingering caveat is that its mechanisms of action and beneficial dosage details are as yet unknown. “We have a trial going on now to find this out,” she said, “but it’s not just about finding out about one or two compounds, it’s about keeping it whole.”

The project is funded by a Phase II $1 million Grand Challenges Explorations (GCE) grant from the Bill and Melinda Gates Foundation. In 2010, Dr. Ryan was awarded a Phase I grant for her program. GCE Phase I grants recognize individuals worldwide who are taking innovative approaches to some of the world’s toughest and persistent global health and development challenges. Phase II recognizes ideas that have made significant progress toward implementation.

There are numerous cultivars of brown rice and Dr. Ryan said the health benefits might be just as distinct as the agronomic varietals. “We don’t know how subtle or drastic cultivar differences are and that’s what we’re doing with our Gates Foundation money,” she said, and noted that she and her team are currently in the early phases of screening cell cultures to begin the process of identifying and testing bran from rice varieties around the globe. Her co-principal investigators are Professor Steve Dow, a leader in mucosal immunology, and University Distinguished Professor Jan Leach in the College of Agricultural Sciences.

In the meantime, Dr. Ryan is excited about the prospect of studying food as a form of medicine. “There’s a lot of opportunity for using food as complementary medicine, particularly in the gut,” she said. “We know that there is an immune system in the gut that responds not just to bacteria, viruses and microbial communities, but also to plant compounds and foods. The combination of the metabolism of the microbes of our foods that also can stimulate our immunities in the gut is an area that has had very little investigation.”

Though pre- and probiotics and probiotic-containing foods are most commonly associated with gut health, Dr. Ryan pointed to a study to which she contributed last year that showed whole rice bran supplementation reduced the susceptibility to a specific strain of Salmonella in mice, and outlined how rice bran helped promote the growth of native lactobacillus in mice.

She explained there’s a big difference between taking a probiotic to colonize bacteria in the gut in comparison to eating foods that nurture the bacteria already native to one’s GI tract. “It’s more of a long-term solution to GI health and improved gut immunity,” she said. “A lot of the microbiome research that’s emerging is talking about the bacteria that’s coming from birth in our gut, it’s not like we can change that drastically but we can modify that by what we eat.

“We know that microbial communities differ in populations around the world,” she continued. “The role of diet is an area that’s been under-investigated, particularly as it relates to the bulk of our staple foods, not just fruits and vegetables. That’s what we consider exciting about rice—it feeds half of humanity and it feeds our microbes. Rice bran has chemical and pre-biotic properties that could have tremendous global health impact by basically preventing and reducing the severity of diarrheal infections.”

Dr. Ryan refrained from discussing what she believed might be an optimal “dose” of rice bran. “I hesitate to use the word dose with food,” she said. “We know very little about moderating dose with food—we always think about limiting our food intake—but if there’s some healthful benefits to our foods we need to think about increasing our intakes."

The Yahoo poster could not post links, Yahoo sucks, but he found the RIBT(NTRZ) tie in>>

Now we're cooking!!! (pun intended)
Just found a reference to Nutracea as a producer of Stabilized Rice Bran in this other powerful Rice Bran research article from Dr. Elizabeth Ryan, Phd. (University of Colorado) titled:

Timely Topics in Nutrition: Bioactive food components and health properties of rice bran (copy & paste)

This reference might be interpreted (still needs direct documentation) that RIBT's Stabilized Rice Bran is probably being studied in the ongoing Bean & Rice Bran research project at Colorado State Univ.-Veterinary Medicine/Biomedical Sciences Dept. by Dr. Ryan and being funded to date by Bill Gates with $1 million.

Dr. Ryan's reference (below) to Nutracea proves she is quite aware of RIBT products including rice bran oil.

EXCERPTED FROM ARTICLE: pages 2 and 6 (worth reading in its entirety)
...
A company (c.) that manufactures rice bran nutritional products entered the market in 2004 with a proprietary technology for stabilizing rice bran. That company produces rice bran foods and dietary supplements for humans and nutritional products for animals, converting several million tons of what was once agricultural waste rice bran into new products. As few as 10 years ago, this rice bran was sold for minimal value for use as animal feed or it was discarded as waste. Use of rice bran foods and nutritional products should continue to grow as additional information is gained on the effects of these products on the health of humans and animals.
...
(c.) NutraCea, Scottsdale, Ariz.

Sorry, no ,link

Original link on the grant>>

http://www.ncbr.com/article/20121204/NEWS/121...source=RSS

Scroll down for more posts ▼

Top 10 Most Recent News Articles

New CMO Joins ARTHEx: Boosting Innovative RNA Focus

Updated Category News Views 26

ARTHEx Biotech's Strategic Expansion Looks like ARTHEx Biotech is shaking things up with some strategic moves by bringing in Dr. Christian Freitag as their new Chief Medical Officer. Now, if you’re knee-deep in the biotech game, you'll know that having someone like Freitag onboard is akin to adding a star player to your lineup. The guy's got more than two decades of...

Continue Reading
Zinzino's October Sales Report: Eye on the Nutritional Prize

Updated Category News Views 38

Delving Into Zinzino's October Performance Alright, let’s cut to the chase and dive headfirst into what really matters—Zinzino AB’s preliminary sales report for October 2026. If you’re banking on the thriving nutritional supplement sector, this Swedish company’s numbers might just be your radar’s blip. October wasn’t just any month for these folks; it was a...

Continue Reading
Are BWIN, LFCR, PCRX Shareholder Deals Fair?

Updated Category News Views 113

What's Really Going On with BWIN, LFCR, and PCRX? Everyone talks about when there's smoke, there's fire. But in this case, it’s hard not to wonder if we're standing knee-deep in burning embers, or just a dusty old campfire. Halper Sadeh LLC is ringing the alarm bells for Baldwin Group, Lifecore Biomedical, and Pacira BioSciences, the trio tagged under NASDAQ: BWIN,...

Continue Reading
Starting Pet End-of-Life Talks: Why Timing Matters

Updated Category News Views 23

Early Conversations Can Change Everything The minute you bring it up, let's be honest, nobody likes to talk about end-of-life decisions, not even for their pets. Yet, when you think about it, biding your time until things get critical isn't doing anyone any favors, especially not the furry ones. Drs. Brandon and Paola Beebout, two piercing minds from Kearney, Nebraska,...

Continue Reading
Kendra Scott's 'Long Live Joy' Campaign Dazzles

Updated Category News Views 40

Unveiling a Holiday Spectacle: 'Long Live Joy' Party hats off, folks, because Kendra Scott is stepping up the holiday game with something they’re calling 'Long Live Joy'. Now, we're not just talking about any run-of-the-mill marketing fluff. This one’s big, it’s colorful, and it’s here to make your accessorized holidays a tad more enchanting. The Multi-Faceted...

Continue Reading
RideNow Gears Up for Earnings Amidst Industry Shifts

Updated Category News Views 185

Highway to Earnings: RideNow's Third Quarter Call Alright, folks, this is the moment the powersports crowd has been itching for. RideNow Group, Inc. (NASDAQ: RDNW) is set to roll out their third-quarter financial results on November 10, 2026. If you're in for a wild ride—pun fully intended—mark this on your calendars. With this company hogging the spotlight in the...

Continue Reading
Duolingo Faces Class Action: Investors React Strongly

Updated Category News Views 63

Duolingo's Rough Road: A Lawsuit in Motion Alright, fasten your seatbelts, because we've got a real rollercoaster here with Duolingo (NASDAQ: DUOL). You know, the language-learning app that's been pushing ads like it's going out of style? Well, investors are seeing red—not the kind you want, either. This class action lawsuit looming over them is like an unwelcome...

Continue Reading
Crocs™ Gains C2C Circularity Gold for Classic Clogs

Updated Category News Views 81

Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...

Continue Reading
Baidu Faces Fraud Allegations: What Investors Should Know

Updated Category News Views 196

Trouble on the Horizon for Baidu Shareholders If you've got a pulse in the world of stock trading, you've likely caught wind of the storm brewing over at Baidu, Inc. (NASDAQ: BIDU). We're talking some heavy-duty allegations of securities fraud, and a class action lawsuit that's got investors scrutinizing their portfolios like never before. The lawsuit's been filed in the...

Continue Reading
AllianceBernstein Unveils Income-Focused ETF Amid Volatile Times

Updated Category News Views 40

Diving into AllianceBernstein's New Income ETF Well, today we’ve got something stirring in the financial waters over at AllianceBernstein. They’ve launched a new exchange-traded fund (ETF), aptly named the AB Equity Premium Income ETF [INK]. Now, if you’re wondering what’s cooking with this newcomer on the NASDAQ, let’s crack it open and see what’s under the...

Continue Reading

Top 5 Most Recently Viewed Articles

Keyo Elevates Rudy Dajie to CEO, Driving Innovative Payments

Updated Category News Views 237

Keyo Appoints Rudy Dajie as New CEO for Advanced Payment Solutions Keyo has recently announced a game-changing leadership appointment with Rudy Dajie stepping into the role of Chief Executive Officer. In a world where artificial intelligence is rapidly evolving, the demand for enhanced security in biometric identification is greater than ever. Innovative Biometric...

Continue Reading
Final Call for $XPL Token Access: Join the XploraDEX Journey

Updated Category News Views 162

Final Chance to Participate in $XPL Token Distribution The $XPL token distribution is entering its crucial final phase, marking an exciting moment for both investors and traders. As the presale of XploraDEX nears its closing date, many are eager to grab their share of the tokens before the opportunity slips away. This innovative platform, set on the XRP Ledger, has the...

Continue Reading
Promising Small-Cap Stocks on the Rise for Investors

Updated Category News Views 73

Small-Cap Stocks on the Verge of Growth As 2024 progresses, many analysts have identified a resurgence in small-cap stocks, suggesting that this year could mark a turning point for these often-overlooked companies. With the economic landscape shifting, especially as interest rates stabilize, there is renewed hope for sectors that faced challenges in previous years....

Continue Reading
Eli Lilly's New Oral Diabetes Treatment Python Results Exceed Expectations

Updated Category News Views 204

Eli Lilly's Groundbreaking Diabetes Treatment Trials Eli Lilly and Company (NYSE: LLY) has made significant advancements in the treatment of type 2 diabetes with their oral medication, orforglipron. Recent Phase 3 trials, ACHIEVE-2 and ACHIEVE-5, have demonstrated impressive results in controlling blood sugar levels among participants. ACHIEVE Trials Overview The...

Continue Reading
Experience Luxury and Performance with the 2025 LC 500 Convertible

Updated Category News Views 63

Introducing the 2025 LC 500 Convertible The 2025 LC 500 Convertible marks another exciting development in the luxury automobile market, maintaining its prestige and allure. This model has undergone a few updates and is ready to impress enthusiasts and casual drivers alike. Standout Features of the 2025 Model This year's model comes with notable enhancements, including...

Continue Reading